These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 4135099)

  • 41. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The natural history and response to therapy of lupus nephritis.
    Ginzler EM; Bollet AJ; Friedman EA
    Annu Rev Med; 1980; 31():463-87. PubMed ID: 6994624
    [No Abstract]   [Full Text] [Related]  

  • 43. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
    Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
    J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
    [No Abstract]   [Full Text] [Related]  

  • 44. [Correlations between the histological changes and results of treatment with corticoids and immunosuppressive agents in primary glomerulonephritis].
    Lagrue G; Bariety J
    Minerva Med; 1970 Jul; 61(55):3054-63. PubMed ID: 5427678
    [No Abstract]   [Full Text] [Related]  

  • 45. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis].
    Haake H; Köneke J; Amann K; vom Dahl J; Janssen U
    Med Klin (Munich); 2007 Oct; 102(10):852-7. PubMed ID: 17928969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Present status and future perspective of RPGN in Japan].
    Usui J; Yamagata K
    Nihon Jinzo Gakkai Shi; 2009; 51(2):78-83. PubMed ID: 19378790
    [No Abstract]   [Full Text] [Related]  

  • 47. Lupus Nephritis.
    Adu D; Cameron JS
    Clin Rheum Dis; 1982 Apr; 8(1):153-82. PubMed ID: 6214362
    [No Abstract]   [Full Text] [Related]  

  • 48. [Controlled trial of cyclophosphamide, azathioprine and chlorambucil in lupus nephritis (the double-blind method)].
    Ivanova MM; Nasonova VA; Solov'ev SK; Akhnazarova VD; Speranskiĭ AI
    Vopr Revm; 1981; (2):11-8. PubMed ID: 7034366
    [No Abstract]   [Full Text] [Related]  

  • 49. Overview of treatment of lupus nephropathy.
    Coggins CH
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):197-200. PubMed ID: 7102668
    [No Abstract]   [Full Text] [Related]  

  • 50. Cytotoxic-drug treatment of lupus nephritis.
    Donadio JV
    N Engl J Med; 1984 Aug; 311(8):528-9. PubMed ID: 6749210
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment with immunosuppressive agents in disseminated lupus erythematosus and in some evolutive nephropathies].
    Purice S; Ghelerter L; Matei I; Brunazian G
    Stud Cercet Med Interna; 1969; 10(2):147-53. PubMed ID: 5344004
    [No Abstract]   [Full Text] [Related]  

  • 52. [The present-day treatment of systemic lupus erythematosus].
    Karchova TIu; Demin AA
    Revmatologiia (Mosk); 1989; (4):59-66. PubMed ID: 2700239
    [No Abstract]   [Full Text] [Related]  

  • 53. [Recommendations for immunosuppressive therapy in systemic lupus erythematosus].
    Deicher H
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):249-51. PubMed ID: 4115641
    [No Abstract]   [Full Text] [Related]  

  • 54. Therapy of autoimmune nephropathy with steroids and cytostatics. A follow-up study of 80 patients and of 16 years.
    Petrányi G; Leövey A; Szegedi G; Kakuk G; Bobory J
    Acta Med Acad Sci Hung; 1971; 28(1):97-106. PubMed ID: 5133501
    [No Abstract]   [Full Text] [Related]  

  • 55. Cyclophosphamide treatment of mouse systemic lupus erythematosus.
    Horowitz RE; Dubois EL; Weiner J; Strain L
    Lab Invest; 1969 Sep; 21(3):199-206. PubMed ID: 4185855
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of immunosuppressive agents on systemic lupus erythematosus].
    Hashimoto H
    Ryumachi; 1976 May; 16(2):174-83. PubMed ID: 959906
    [No Abstract]   [Full Text] [Related]  

  • 57. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents.
    Vasquez S; Kavanaugh AF; Schneider NR; Wacholtz MC; Lipsky PE
    J Rheumatol; 1992 Oct; 19(10):1625-7. PubMed ID: 1464880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine.
    Donadio JV; Holley KE; Wagoner RD; Ferguson RH; McDuffie FC
    Arthritis Rheum; 1974; 17(5):573-81. PubMed ID: 4278104
    [No Abstract]   [Full Text] [Related]  

  • 59. [Systemic lupus erythematosus. Etiopathogenesis and immunosuppressive therapy].
    Clément F
    Schweiz Med Wochenschr; 1973 Oct; 103(40):1369-77. PubMed ID: 4755631
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug therapy: immunosuppressive agents (second of two parts).
    Kaplan SR; Calabresi P
    N Engl J Med; 1973 Dec; 289(23):1234-6. PubMed ID: 4594161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.